Work

Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design

Year: 2015

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2015.12.009

Authors: Lawrence R. Kleinberg, Paul J. Catalano, Arlene A. Forastiere, Steven M. Keller, Edith P. Mitchel, Pramila Rani Anne, Al B. Benson

Institutions: Johns Hopkins University, Harvard University, Dana-Farber Cancer Institute, Montefiore Medical Center, Montefiore Health System, Thomas Jefferson University, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: ECOG Statistical Office Data Management Grant, G1422427855, ECOG-ACRIN Network Group Operations Center, EASTERN COOPERATIVE ONCOLOGY GROUP, G332150848, Eastern Cooperative Oncology Group, G3800835027, ECOG Clinical Trials, G4412485521, G5765316850, Eastern Cooperative Oncology Group, ECOG-ACRIN Network Group Statistics and Data Management Center, ECOG Statistical Office, Eastern Cooperative Oncology Group Operations Office, The Robert H. Lurie Comprehensive Cancer Center, Regional Oncology Research Center, G964706321

OpenAlex ID: W2274428375

FWCI: 1.556

Cites: 46

Cited by: 19

Related to: 10